🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Status
Unknown
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-06
Trial ID
NCT05420493
Treatments Being Tested
The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Status
Not Yet Recruiting
Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Start Date
2025-09-30
Trial ID
NCT07161193
Treatments Being Tested
The main purpose of this study is to explore the sequential therapeutic eff...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02737085
Treatments Being Tested
This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-12-29
Trial ID
NCT07509086
Treatments Being Tested
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2015-05-18
Trial ID
NCT02208362
Treatments Being Tested
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Status
Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Start Date
2025-12-01
Trial ID
NCT07305116
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This phase I trial studies the side effects and best dose of BCMA CART cell...
Status
Unknown
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Start Date
2018-06-02
Trial ID
NCT03767725
Treatments Being Tested